Article 4
December 29, 2009 Study disputes ‘healthy and obese’ fallacy Study Debunks Notion of ‘Healthy Obese’ Man – BusinessWeek December 29, 2009 Vivus announces plans to submit Qnexa for FDA approval Vivus...
View ArticleLast Gasp for Qnexa?
September 21, 2010 Vivus Pharmaceuticals announced today the results of the two-year study of their drug for obesity, Qnexa. The findings show, after two years, an 11% or 26 pound weight loss with...
View ArticleFDA Goes AWOL on Obesity
Today the Food and Drug Administration (FDA) rejected the application of Vivus Pharmaceuticals Inc for approval of their drug, Qnexa, for the treatment of obesity. According to Morgan Downey, Editor...
View ArticleFDA Spikes Another Obesity Drug
Orexigen Therapeutics Inc. indicated today that the Food and Drug Administration (FDA) has, in effect, decided not to approve the company’s obesity drug, Contrave ® in spite of a federal advisory panel...
View ArticleQnexa’s Second Chance
Vivus Inc. has indicated that the FDA will accept a resubmission of the application and hold a second Advisory Committee on Qnexa in early 2012. Early indications are the revisions would indicate a...
View Article
